EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression. - Wang, Chenyu; Li, Xingwang; Zhang, Junjie; Ge, Zheng; Chen, Hejin; Hu, Junhong (OncoTargets & Therapy, 2018)